MedImprove
ActiveSummary
MedImprove has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €301,052 and a net result of €176,363. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 30% of 268 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- “Bestuurder van BV TAXACIBO” (deed in Dutch)
Read from the deeds: 1 provision, deed of 15-12-2025